Dijous 11 de juny, el Dipòsit Digital no estarà operatiu de 15:00 a 17:00 h per tasques de manteniment. Disculpeu les molèsties.
El jueves 11 de Junio, el Dipòsit Digital no estará operativo de 15:00 a 17:00 h debido a tareas de mantenimiento. Disculpen las molestias.
Thursday, Jun 11th, the Digital Repository will be unavailable due to a system update.

Document type

Article

Version

Published version

Publication date

Publication license

cc-by (c) Afelik, Solomon et al., 2017
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/172610

Pancreatic β-cell regeneration: advances in understanding the genes and signaling pathways involved.

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

Diabetes mellitus is a metabolic disorder characterized by dysfunction, loss, or insufficient mass of β cells. The main function of β cells is to produce and secrete insulin, the hormone responsible for the regulation of blood glucose levels. Type 1 diabetes (T1D) results from autoimmune destruction of β cells, while type 2 diabetes (T2D) mostly results from β-cell dysfunction or peripheral tissue resistance to insulin, often culminating in β-cell death. Thus, both forms of diabetes can benefit from restoration of β-cell mass. Currently, islet transplantation is the only way to provide new β cells to diabetic patients, but the scarcity of compatible cadaveric donors makes this approach available to only few patients; moreover, it requires lifelong immune suppression.

Subject (English)

Citation

Citation

AFELIK, Solomon and ROVIRA, Meritxell. Pancreatic β-cell regeneration: advances in understanding the genes and signaling pathways involved. Genome Medicine. 2017. Vol. 9, num. 42. ISSN 1756-994X. [consulted: 12 of June of 2026]. Available at: https://hdl.handle.net/2445/172610

Export metadata

JSON - METS

Share record